---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-003846"
form_type: "8-K"
ticker: "NWBO"
cik: "0001072379"
company_name: "NORTHWEST BIOTHERAPEUTICS INC"
filed_at: "2023-01-13T23:59:59+00:00"
generated_at: "2026-06-20T15:10:30.231042+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Northwest Biotherapeutics increases authorized common shares from 1.2B to 1.7B

## Summary
- Filed Certificate of Amendment with Delaware Secretary of State on January 9, 2023.
- Authorized shares of common stock increased by 500 million to 1.7 billion; par value remains $0.001.
- No concurrent offering or use of proceeds disclosed in the filing.

## SEC filing metadata
- accession: 0001104659-23-003846
- form_type: 8-K
- ticker: NWBO
- cik: 0001072379
- company_name: NORTHWEST BIOTHERAPEUTICS INC
- filed_at: 2023-01-13T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1072379/000110465923003846/0001104659-23-003846-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1072379/000110465923003846/tm233422d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-003846
- JSON: https://secwatch.observer/filing/0001104659-23-003846.json
- Plain text: https://secwatch.observer/filing/0001104659-23-003846.txt

## Key facts
- Governance Changes
  NORTHWEST BIOTHERAPEUTICS INC: Increased authorized shares of common stock from 1,200,000,000 to 1,700,000,000 (effective 2023-01-09).
  - Change: charter amendment
  - Effective: 2023-01-09
  source text: On January 9, 2023, the Company filed a Certificate of Amendment of its Seventh Amended and Restated Certificate of Incorporation (the “Certificate of Amendment”) with the Secretary of the State of Delaware, which effected an increase in the Company’s authorized shares of common stock, from 1,200,000,000 to 1,700,000,000, par value $0.001 per share.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1072379/000110465923003846/0001104659-23-003846-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.